Eagle Veterinary Technology Co.,Ltd announces an Equity Buyback for KRW 2,100 million worth of its shares.
November 03, 2016
Share
Eagle Veterinary Technology Co.,Ltd (KOSDAQ:A044960) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,100 million worth of its shares pursuant to a trust contract with Daishin Securities Co. Ltd. The purpose of the share repurchase program is to improve shareholder value through stock price stabilization. The share repurchase program is valid until November 3, 2017. As of November 2, 2016, the company had no shares in treasury within scope available for dividend and had no shares in treasury through other repurchase.
Eagle Veterinary Technology Co.,Ltd is a Korea-based company engaged in the manufacture and marketing of veterinary medicines. The Companyâs main products are veterinary medicines, including anthelmintics, antibiotics, analgesic agents, antibacterials, anti-inflammatory agents, disinfectants, probiotics, nutrients and others in the forms of soluble powders, oral liquids, oral tablets and injections. The Companyâs products are used for bovine, swine, poultry, fishes and companion animals. It also engages in the leasing of real estate. The Company distributes its products within domestic market and to overseas markets.
EAGLE VETERINARY TECHNOLOGY CO.,LTD 
